Payden & Rygel Investment Group Zoetis Inc. Transaction History

Payden & Rygel Investment Group

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Oct 08, 2024	SELL	$165.67 - $199.94 $5.4 Million - $6.52 Million	-32,600 Reduced 31.47%	70,990 $12 Million
Q1 2024 May 13, 2024	SELL	$165.67 - $199.94 $5.4 Million - $6.52 Million	-32,600 Reduced 31.47%	70,990 $12 Million
Q3 2023 Oct 08, 2024	BUY	$167.14 - $192.77 $17.3 Million - $20 Million	103,590 New	103,590 $18 Million
Q3 2023 Nov 08, 2023	BUY	$167.14 - $192.77 $17.3 Million - $20 Million	103,590 New	103,590 $18 Million

1,956

412M

1.02M

1.09M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $82.8B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of Payden & Rygel Investment Group, based on Form 13F filings with the SEC.

Stay updated on Payden & Rygel Investment Group with notifications on news.